7zl9
From Proteopedia
(Difference between revisions)
m (Protected "7zl9" [edit=sysop:move=sysop]) |
|||
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of human GPCR Niacin receptor (HCA2)== | |
- | + | <StructureSection load='7zl9' size='340' side='right'caption='[[7zl9]], [[Resolution|resolution]] 2.70Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[7zl9]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7ZL9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7ZL9 FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.7Å</td></tr> | |
- | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=OLA:OLEIC+ACID'>OLA</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=UNX:UNKNOWN+ATOM+OR+ION'>UNX</scene></td></tr> |
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7zl9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7zl9 OCA], [https://pdbe.org/7zl9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7zl9 RCSB], [https://www.ebi.ac.uk/pdbsum/7zl9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7zl9 ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/C562_ECOLX C562_ECOLX] Electron-transport protein of unknown function.[https://www.uniprot.org/uniprot/HCAR2_HUMAN HCAR2_HUMAN] Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis. The rank order of potency for the displacement of nicotinic acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid = nicotinamide.<ref>PMID:17932499</ref> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Escherichia coli]] | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: FiBerto JF]] | ||
+ | [[Category: Gao RG]] | ||
+ | [[Category: Han GW]] | ||
+ | [[Category: Kang HJ]] | ||
+ | [[Category: Kenakin T]] | ||
+ | [[Category: Li XM]] | ||
+ | [[Category: Liu ZJ]] | ||
+ | [[Category: Peng W]] | ||
+ | [[Category: Pileski R]] | ||
+ | [[Category: Qu L]] | ||
+ | [[Category: Rao ZH]] | ||
+ | [[Category: Roth BL]] | ||
+ | [[Category: Stevens RC]] | ||
+ | [[Category: Tong JH]] | ||
+ | [[Category: Wang JJ]] | ||
+ | [[Category: Wang Q]] | ||
+ | [[Category: Wu LJ]] | ||
+ | [[Category: Wu YR]] | ||
+ | [[Category: Yang Y]] | ||
+ | [[Category: Zhang XC]] | ||
+ | [[Category: Zhao SW]] |
Current revision
Crystal structure of human GPCR Niacin receptor (HCA2)
|
Categories: Escherichia coli | Homo sapiens | Large Structures | FiBerto JF | Gao RG | Han GW | Kang HJ | Kenakin T | Li XM | Liu ZJ | Peng W | Pileski R | Qu L | Rao ZH | Roth BL | Stevens RC | Tong JH | Wang JJ | Wang Q | Wu LJ | Wu YR | Yang Y | Zhang XC | Zhao SW